A Novel Drug for Borderline Personality Disorder
NCT02097706
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
150
Enrollment
OTHER
Sponsor class
Conditions
Borderline Personality Disorder
Interventions
DRUG:
NMDA receptor antagonist (active drug)
OTHER:
Lactose packed capsule (inert/inactive arm)
Sponsor
The Alfred